Literature DB >> 12928296

Ocular myasthenia gravis and inflammatory bowel disease: a case report and literature review.

R Foroozan, R Sambursky.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12928296      PMCID： PMC1771868          DOI： 10.1136/bjo.87.9.1186

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Myasthenia gravis coexistent with Crohn's disease.

Authors:  R W Martin; A Shah
Journal:  J Clin Gastroenterol       Date:  1991-02       Impact factor: 3.062

Review 2.  The spectrum of diseases associated with thymoma. Coincidence or syndrome?

Authors:  J V Souadjian; P Enriquez; M N Silverstein; J M Pépin
Journal:  Arch Intern Med       Date:  1974-08

3.  Myasthenia gravis, ulcerative colitis and lichen planus.

Authors:  T N Miller
Journal:  Proc R Soc Med       Date:  1971-08

4.  Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo.

Authors:  R S Tan
Journal:  Proc R Soc Med       Date:  1974-03

5.  The association of carcinoembryonic antigen and peripheral lymphocytes.

Authors:  A E Papatestas; U Kim; G Genkins; P Kornfeld; S H Horowitz; A H Aufses
Journal:  Surgery       Date:  1975-09       Impact factor: 3.982

6.  Remission of myasthenia gravis after proctocolectomy in a patient with ulcerative colitis.

Authors:  C Gower-Rousseau; D Reumaux; M Bellard; L Delecourt; M Ribet; J F Colombel
Journal:  Am J Gastroenterol       Date:  1993-07       Impact factor: 10.864

7.  Crohn's disease and myasthenia gravis: a possible role for thymectomy.

Authors:  I A Finnie; R Shields; R Sutton; R Donnelly; A I Morris
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

8.  Neurologic aspects of inflammatory bowel disease.

Authors:  A Lossos; Y River; A Eliakim; I Steiner
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

9.  Characterization of thymus cells in hyperplastic thymuses in patients with myasthenia gravis and ulcerative colitis with monoclonal antibodies.

Authors:  S Aiso; T Yoshida; M Watanabe; T Hibi; H Asakura; M Tsuchiya; S Tsuru
Journal:  J Clin Lab Immunol       Date:  1984-03
  9 in total
  4 in total

1.  Associated thyreoiditis, myasthenia gravis, thymectomy, Chron's disease, and erythema nodosum: pathogenetic and clinical correlations, immune system involvement, and systemic infectious complications.

Authors:  Roberto Manfredi; Giovanni Fasulo; Ciro Fulgaro; Sergio Sabbatani
Journal:  Rheumatol Int       Date:  2008-04-04       Impact factor: 2.631

Review 2.  Inflammatory bowel disease: an increased risk factor for neurologic complications.

Authors:  Germán Morís
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 3.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 4.  Ophthalmic manifestations in patients with inflammatory bowel disease: A review.

Authors:  Leandro Lopes Troncoso; Ana Luiza Biancardi; Haroldo Vieira de Moraes; Cyrla Zaltman
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.